Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: jackie who wrote (10620)	7/5/1999 7:12:00 PM
From: aknahow	Respond to of 17367

Jackie, yes I think a Barron's article, "Pavlov's funds" page F12 July 5, provides an interesting comment on the psychology of investors also treat a stock like dirt. XOMA comes to mind, but I am not suggesting the funds mentioned would think it meets their criteria, since XOMA has no sales nor earnings. "...his first order of businesses to identify companies whose earnings and stock prices have lagged their peers' for an extended period, because ""if humans are exposed to a long sequence of negative results, they give up and assume the future will be the same." Often these companies are so disliked that investors have ""lost confidence in management."" IMO XOMA fits into this category and the market will probably ignore the psoriasis presentation, the look back news and the MS implications. But someday, IMO, people will pay attention. That is one of the reasons I don't write off the importance of market letters, analyst reports nor Harry Dent. jackie the post does not seem related to yours but it is. Just as the peers treated the guy you mention as dirt, a lot of smart people, in the market, ignore everything and anyhing related to XOMA because in their opinion it is less than dirt.